Korean Circ J.  2022 Nov;52(11):826-828. 10.4070/kcj.2022.0265.

Clinical Utility of Coronary Computed Tomography Angiography, Beyond the Gatekeeper for Invasive Coronary Angiography

• Yoon YE

• KMID: 2534902
• DOI: http://doi.org/10.4070/kcj.2022.0265

Reference

1. Wolk MJ, Bailey SR, Doherty JU, et al. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014; 63:380–406. PMID: 24355759.

2. Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013; 34:2949–3003. PMID: 23996286.

3. Abdelrahman KM, Chen MY, Dey AK, et al. Coronary computed tomography angiography from clinical uses to emerging technologies: JACC state-of-the-art review. J Am Coll Cardiol. 2020; 76:1226–1243. PMID: 32883417.

4. Cha MJ, Kim WD, Won H, et al. Nationwide trends of gatekeeper to invasive coronary angiography in suspected coronary artery disease. Korean Circ J. 2022; 52:814–825. PMID: 36217588.

5. Hwang IC, Lee H, Yoon YE, et al. Risk stratification of non-obstructive coronary artery disease for guidance of preventive medical therapy. Atherosclerosis. 2019; 290:66–73. PMID: 31586872.

6. Hoffmann U, Ferencik M, Udelson JE, et al. Prognostic value of noninvasive cardiovascular testing in patients with stable chest pain: insights from the PROMISE trial (prospective multicenter imaging study for evaluation of chest pain). Circulation. 2017; 135:2320–2332. PMID: 28389572.

7. SCOT-HEART investigators. CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. Lancet. 2015; 385:2383–2391. PMID: 25788230.

8. Douglas PS, Hoffmann U, Patel MR, et al. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med. 2015; 372:1291–1300. PMID: 25773919.

9. Newby DE, Adamson PD, Berry C, et al. Coronary CT angiography and 5-year risk of myocardial infarction. N Engl J Med. 2018; 379:924–933. PMID: 30145934.

10. Motoyama S, Sarai M, Harigaya H, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol. 2009; 54:49–57. PMID: 19555840.

11. Narula J, Nakano M, Virmani R, et al. Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. J Am Coll Cardiol. 2013; 61:1041–1051. PMID: 23473409.

12. Williams MC, Moss AJ, Dweck M, et al. Coronary artery plaque characteristics associated with adverse outcomes in the SCOT-HEART study. J Am Coll Cardiol. 2019; 73:291–301. PMID: 30678759.

13. Kay FU, Canan A, Abbara S. Future directions in coronary CT angiography: CT-fractional flow reserve, plaque vulnerability, and quantitative plaque assessment. Korean Circ J. 2020; 50:185–202. PMID: 31960635.

14. Lee SE, Chang HJ, Sung JM, et al. Effects of statins on coronary atherosclerotic plaques: the PARADIGM study. JACC Cardiovasc Imaging. 2018; 11:1475–1484. PMID: 29909109.